Chaince Digital Holdings Inc. (CD) vs Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII)

A side-by-side comparison of Chaince Digital Holdings Inc. and Drugs Made In America Acquisition II Corp. Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Chaince Digital Holdings Inc. logo
CD
Chaince Digital Holdings Inc.
$655M
$8.25Financial ServicesDelayed quote: Oct 6, 2026, 1:00 PM EDT
Drugs Made In America Acquisition II Corp. Ordinary Shares logo
DMII
Drugs Made In America Acquisition II Corp. Ordinary Shares
$649M
$10.19Financial ServicesDelayed quote: Oct 6, 2026, 12:19 PM EDT

Total return — CD vs DMII

growth of $100 · dividends reinvested · last 1y
CD -12.8% (-12.8%/yr)DMII +3.1% (+3.1%/yr)DMII compounded faster over this window
406080100Start $1002026$87$103
CD DMII

Metrics side by side

Total return (annualized)

MetricCDDMII
Total return (1Y)-74.30%N/A
Total return CAGR (3Y)84.77%N/A
Total return CAGR (5Y)25.53%N/A
Total return CAGR (10Y)-21.62%N/A

CD is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full CD analysisFull DMII analysisInteractive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.